SCHEDULE 13G/A – Description Post author:andrewkaretas Post published:February 13, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue ReadingSCHEDULE 13G/A – Description
SCHEDULE 13G/A – Description Post author:andrewkaretas Post published:February 13, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue ReadingSCHEDULE 13G/A – Description
SCHEDULE 13G/A – Description Post author:andrewkaretas Post published:February 12, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue ReadingSCHEDULE 13G/A – Description
4: Statement of changes in beneficial ownership of securities Post author:andrewkaretas Post published:February 5, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading4: Statement of changes in beneficial ownership of securities
4: Statement of changes in beneficial ownership of securities Post author:andrewkaretas Post published:February 5, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading4: Statement of changes in beneficial ownership of securities
4: Statement of changes in beneficial ownership of securities Post author:andrewkaretas Post published:February 5, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading4: Statement of changes in beneficial ownership of securities
4: Statement of changes in beneficial ownership of securities Post author:andrewkaretas Post published:February 5, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading4: Statement of changes in beneficial ownership of securities
4: Statement of changes in beneficial ownership of securities Post author:andrewkaretas Post published:February 5, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading4: Statement of changes in beneficial ownership of securities
144: Filed by “insiders” prior intended sale of restricted stock. Non-EDGAR filing Post author:andrewkaretas Post published:February 3, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading144: Filed by “insiders” prior intended sale of restricted stock. Non-EDGAR filing
144: Filed by “insiders” prior intended sale of restricted stock. Non-EDGAR filing Post author:andrewkaretas Post published:February 3, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading144: Filed by “insiders” prior intended sale of restricted stock. Non-EDGAR filing